We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Significant progress has been made in developing medicines for children since implementation of pediatric legislation in the US (1997) and EU (2006). However, gaps still exist, and regulatory authorities continue to address them.